Company: GIFLF
Filing Date: 2025-11-04
Form Type: 6-K
Source: 0001104659-25-106104
Chunk: 3

Company: Grifols SA
Filing Date: 2025-11-04
Form: 6-K
Chunk 3
---
 approval to begin manufacturing Gel Cards and reagent Red Blood Cells at Grifols’ San Diego facility.

Grifols 2025 guidance

Assuming current FX rates remain unchanged for the remainder of the year, full year FX headwinds versus Guidance FX rates are estimated to be EUR c.70 million for Adjusted EBITDA and broadly neutral for group profit, free cash flow and leverage.

| 1 | Operating                                                                          
 or constant currency (cc) excludes changes rate variations reported in the period. |

| 2 | Calculated                                                                                    
 as EBITDA Adjusted - Net Working Capital - CAPEX (including capitalized IT and R&D, and       
 extraordinary growth CAPEX) - Others - Interest - Taxes. In the Consolidated Annual Accounts, 
 this reconciles to Cash flow generation from operating and inve sting activities excluding    
 impact from M&A and associated costs and expenses. Excludes lease payments, consistent        
 with prior disclosed guidance.                                                                |

| 3 | Guidance                                                                                     
 FX rate refers to FX rates as at 27 Feb 2025, consistent with page 38 of the Capital Markets 
 Day (CMD) presentation (EUR USD @ 1.04).                                                     |

Page 2 of 4

Alternative Performance Measures (APMs)

This document contains the following Alternative Performance Measures (APMs): Consolidated EBITDA Reported, Consolidated EBITDA Adjusted, Leverage Ratio as per the Credit Facility, Net Debt as per the Credit Facility, Free Cash Flow, Working Capital, and non-recurring items. For further details on the definition, explanation on the use, and reconciliation of APMs, please see the Appendix of the Presentation as well as the “Alternative Performance Measures” document from Grifols website www.grifols.com/en/investors.

CONFERENCE CALL

Grifols will host a conference call today, November 4, 2025, at 18:30 CET / 12:30 EST to discuss its financial results for the third quarter of 2025. To view and listen to the webcast and view the presentation, click on Q3 2025 Resultsor visit the website www.grifols.com/en/investors. Participants are advised to register in advance of the conference call.

MEDIA

Grifols Press Office

media@grifols.com

Tel. +34 93 571 00 02

INVESTORS

Investors Relations & Sustainability

inversores@grifols.com- investors@grif